These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22550208)

  • 1. Neuromuscular blockade and skeletal muscle weakness in critically ill patients: time to rethink the evidence?
    Puthucheary Z; Rawal J; Ratnayake G; Harridge S; Montgomery H; Hart N
    Am J Respir Crit Care Med; 2012 May; 185(9):911-7. PubMed ID: 22550208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuromuscular Blockade in the Critically Ill].
    Jung C; Stüber T
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2024 Aug; 59(9):506-516. PubMed ID: 39197442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse responses: sedation, analgesia and neuromuscular blocking agents in critically ill children.
    Sorce LR
    Crit Care Nurs Clin North Am; 2005 Dec; 17(4):441-50, xi-xii. PubMed ID: 16344213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular Blocking Agents and Neuromuscular Dysfunction Acquired in Critical Illness: A Systematic Review and Meta-Analysis.
    Price DR; Mikkelsen ME; Umscheid CA; Armstrong EJ
    Crit Care Med; 2016 Nov; 44(11):2070-2078. PubMed ID: 27513545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should ICU patients receive muscle relaxants?
    Coakley J
    Schweiz Med Wochenschr; 1996 Sep; 126(39):1644-8. PubMed ID: 8858758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticosteroids and neuromuscular blockers in development of critical illness neuromuscular abnormalities: A historical review.
    Wilcox SR
    J Crit Care; 2017 Feb; 37():149-155. PubMed ID: 27736708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional recovery after neuromuscular blockade in mechanically ventilated critically ill patients.
    Whetstone Foster JG; Clark AP
    Heart Lung; 2006; 35(3):178-89. PubMed ID: 16701112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between neuromuscular blocking agents and the development of intensive care unit-acquired weakness (ICU-AW): A systematic review with meta-analysis and trial sequential analysis.
    Bellaver P; Schaeffer AF; Leitao CB; Rech TH; Nedel WL
    Anaesth Crit Care Pain Med; 2023 Jun; 42(3):101202. PubMed ID: 36804373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular Blockade in the 21st Century Management of the Critically Ill Patient.
    deBacker J; Hart N; Fan E
    Chest; 2017 Mar; 151(3):697-706. PubMed ID: 27818334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive care unit-acquired weakness: unanswered questions and targets for future research.
    Piva S; Fagoni N; Latronico N
    F1000Res; 2019; 8():. PubMed ID: 31069055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Train-of-four results and observed muscle movement in children during continuous neuromuscular blockade.
    Corso L
    Crit Care Nurse; 2008 Jun; 28(3):30-8; quiz 39. PubMed ID: 18515606
    [No Abstract]   [Full Text] [Related]  

  • 12. A review of neuromuscular blockade in the critically ill patient.
    Burry L; HoSang M; Hynes-Gay P
    Dynamics; 2001; 12(3):28-33; quiz 34-5. PubMed ID: 11982205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of neuromuscular electrical stimulation in critically ill patients.
    Segers J; Hermans G; Bruyninckx F; Meyfroidt G; Langer D; Gosselink R
    J Crit Care; 2014 Dec; 29(6):1082-8. PubMed ID: 25108833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromuscular disorders in critical illness.
    Pandit L; Agrawal A
    Clin Neurol Neurosurg; 2006 Oct; 108(7):621-7. PubMed ID: 16730883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current status for animal models of intensive care unit acquired muscle weakness].
    Zou W; Liu F; Li J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jun; 43(6):691-696. PubMed ID: 30110014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sedation and neuromuscular blockade in patients with acute respiratory failure.
    Luer JM
    Crit Care Nurse; 2000 Oct; 20(5):84-9. PubMed ID: 11878492
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of neuromuscular blocking agents in the development of polyneuropathy and myopathy in critically ill patients.
    Armestar F; Vitoria Rubio S; Ojanguren Sabán I; Coll-Cantí J; Perez Molto H
    Med Clin (Barc); 2024 Oct; 163(7):323-326. PubMed ID: 38960793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications associated with sedative and neuromuscular blocking drugs in critically ill patients.
    Prielipp RC; Coursin DB; Wood KE; Murray MJ
    Crit Care Clin; 1995 Oct; 11(4):983-1003. PubMed ID: 8535989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual neuromuscular blockade: importance of upper airway integrity.
    Gal TJ
    Anesthesiology; 2004 Feb; 100(2):457; author reply 458. PubMed ID: 14739831
    [No Abstract]   [Full Text] [Related]  

  • 20. Two identical episodes of acute quadriparesia in an intensive care unit patient.
    Kohler A; Jolliet P; Schnorf H; Magistris MR
    Intensive Care Med; 1998 Aug; 24(8):891-2. PubMed ID: 9757940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.